Lusia Guthrie

Lusia Guthrie


Lusia Guthrie

Non-Executive Director

Chair of the Regulatory & Quality Committee

With over 35 years in the pharmaceutical and bioscience industries, Lusia Guthrie is an experienced executive and med-tech entrepreneur, with strong leadership skills and international industry networks.  She started her career as a Medical Laboratory Scientist before joining the Manufacturing Division of pharmaceutical company FH Faulding & Co where she attained the position of Director of Operations.  Lusia then went on to co-found medical technology innovation company LBT Innovations Limited (ASX: LBT) where she served as Chief Executive Officer and Managing Director until 2016.

Lusia has a passion and proven track record in bringing innovative products to global markets, embracing the entire process from company formation, capital raising and concept development to product launch.  She has particular experience and ongoing interest in the development and commercialisation of new healthcare products that embrace automation, robotics, machine learning and artificial intelligence.

Current Board and Committee roles:

  • Chairman, Clever Culture Systems AG (Zurich)
  • Non-Executive Director, 4Dx Limited
  • Deputy Chair, BioMelbourne Network
  • Director, ANDHealth
  • Chair, Advisory Committee – Medicines Manufacturing Innovation Centre, Monash University (MMIC)
  • Member, Advisory Board – Australian Regenerative Medicine Institute (ARMI)

Lusia previously served on the Manufacturing Consultative Committee for the State Government of South Australia and was a Member of the Future Manufacturing Industry Innovation Council for the Commonwealth Department of Industry, Innovation, Science and Research.

Lusia holds a Bachelor of Applied Science (Medical Technology) from the University of South Australia and a Master of Science (Science and Technology Commercialisation) from the University of Adelaide.